Department of Laboratory Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Clinical Medicine, Hangzhou Normal University Qianjiang College, Hangzhou, China.
Ann Nutr Metab. 2018;72(1):30-36. doi: 10.1159/000484255. Epub 2017 Dec 12.
We aimed to explore the association between urinary alpha1-microglobulin (A1M) levels and nonalcoholic fatty liver disease (NAFLD) in a Chinese population.
We performed a cross-sectional study among 2,215 Chinese who attended their annual health examination at First Affiliated Hospital, College of Medicine, Zhejiang University. Urinary A1M-creatinine ratio and other clinical and laboratory parameters were measured.
A total of 20.9% of subjects fulfilled the diagnostic criteria of NAFLD. NAFLD subjects had significantly higher urinary A1M-creatinine ratios. These levels were positively associated with NAFLD prevalence. The association between A1M-creatinine ratio and NAFLD was independent of hyperglycemia status. Stepwise regression showed that urinary A1M-creatinine ratio was significantly associated with the risk for NAFLD. Urinary A1M-creatinine ratio was an independent factor predicting advanced fibrosis (FIB-4 ≥1.3) in NAFLD patients.
Our results showed a significant association between urinary A1M-creatinine ratio and NAFLD.
本研究旨在探讨中国人群尿α1-微球蛋白(A1M)水平与非酒精性脂肪性肝病(NAFLD)之间的关系。
我们对在浙江大学医学院附属第一医院接受年度体检的 2215 名中国人进行了横断面研究。测量了尿 A1M-肌酐比值和其他临床及实验室参数。
共有 20.9%的受试者符合 NAFLD 的诊断标准。NAFLD 患者的尿 A1M-肌酐比值显著升高。这些水平与 NAFLD 的患病率呈正相关。A1M-肌酐比值与 NAFLD 的相关性独立于高血糖状态。逐步回归显示,尿 A1M-肌酐比值与 NAFLD 的风险显著相关。尿 A1M-肌酐比值是预测 NAFLD 患者发生肝纤维化(FIB-4≥1.3)的独立因素。
本研究结果表明,尿 A1M-肌酐比值与 NAFLD 之间存在显著相关性。